Myocardial function in patients with multiple sclerosis treated with low-dose mitoxantrone
- 1 May 2002
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 89 (10) , 1222-1225
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- LATE CARDIAC DAMAGE OF ANTHRACYCLINE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDHOODPediatric Hematology and Oncology, 2000
- Treatment of multiple sclerosis: recent trials and future perspectivesCurrent Opinion in Neurology, 1999
- Early Detection of Anthracycline-Induced Cardiotoxicity by Radionuclide AngiocardiographyAngiology, 1999
- Doppler evaluation of left and right ventricular diastolic function: A technical guide for obtaining optimal flow velocity recordingsJournal of the American Society of Echocardiography, 1997
- Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcomeJournal of Neurology, 1997
- Review of Tests for Monitoring Doxorubicin-lnduced CardiomyopathyOncology, 1996
- Noninvasive Assessment of Mitoxantrone Cardiotoxicity in Relapsing Remitting Multiple SclerosisThe Journal of Clinical Pharmacology, 1995
- Early detection of doxorubicin and daunorubicin cardiotoxicity by echocardiography: Diastolic versus systolic parametersEuropean Journal of Pediatrics, 1995
- Late Cardiac Toxicity of Doxorubicin, Epirubicin, and Mitoxantrone Therapy for Hodgkin's Disease in AdultsLeukemia & Lymphoma, 1993
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989